Sysnav Healthcare is participating in MDA 2024

Sysnav Healthcare at the 2024 MDA

Sysnav Healthcare is thrilled to announce its participation in the 2024 MDA Clinical & Scientific Conference in Orlando from 3rd March to 6th March 2024.
Our Healthcare Program Director, Damien Eggenspieler, and Healthcare Partnerships Lead, Yacine Bechichi attended the conference.
 
Are you interested in learning more about us or our Syde digital endpoint platform? You can already schedule a meeting with them here !

We presented scientific research projects on Duchenne Muscular Dystrophy (DMD) and Amyotrophic Lateral Sclerosis (ALS):

  • DMD: Longitudinal multicentric study to validate SV95C in ambulant DMD aged 2-15 years old. You can download it here.
  • ALS: Digital mobility outcome measure in patients with amyotrophic lateral sclerosis. You can download it here.

More To Explore

Sysnav Healthcare at ICNMD 2026
Events

Sysnav Healthcare at ICNMD 2026

How do you assess a patient too young to follow instructions? That’s the challenge our Program Director, Damien Eggenspieler, tackled on the ground at ICNMD

Sysnav Healthcare at EAN
Events

Sysnav Healthcare at EAN 2026

Can a single wearable platform derive meaningful clinical conclusions across 10+ neurological diseases? The evidence says yes.We’re presenting three new posters at EAN 2025, each

Sysnav Healthcare is participating in ENCALS 2026
Events

Sysnav Healthcare at ENCALS 2026

As the development of innovative therapies for ALS accelerates around the world, the need for objective and clinically meaningful measures of disease progression has never